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Abstract
Much of the complexity of biochemical networks comes from the information-processing abilities of allosteric proteins, be
they receptors, ion-channels, signalling molecules or transcription factors. An allosteric protein can be uniquely regulated by
each combination of input molecules that it binds. This ‘‘regulatory complexity’’ causes a combinatorial increase in the
number of parameters required to fit experimental data as the number of protein interactions increases. It therefore
challenges the creation, updating, and re-use of biochemical models. Here, we propose a rule-based modelling framework
that exploits the intrinsic modularity of protein structure to address regulatory complexity. Rather than treating proteins as
‘‘black boxes’’, we model their hierarchical structure and, as conformational changes, internal dynamics. By modelling the
regulation of allosteric proteins through these conformational changes, we often decrease the number of parameters
required to fit data, and so reduce over-fitting and improve the predictive power of a model. Our method is
thermodynamically grounded, imposes detailed balance, and also includes molecular cross-talk and the background activity
of enzymes. We use our Allosteric Network Compiler to examine how allostery can facilitate macromolecular assembly and
how competitive ligands can change the observed cooperativity of an allosteric protein. We also develop a parsimonious
model of G protein-coupled receptors that explains functional selectivity and can predict the rank order of potency of
agonists acting through a receptor. Our methodology should provide a basis for scalable, modular and executable
modelling of biochemical networks in systems and synthetic biology.
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Introduction
A goal of biology is to understand the structure and function of
the biochemical networks that underpin cellular decision-making.
One organizing principle is that these networks are inherently
modular [1–3], with specific functions ascribed to a subset of
proteins in the network. Yet, like logic gates in electronic circuits,
even individual proteins can perform sophisticated computations
and integrate multiple inputs [4–7]. In engineering, a modular
approach to the analysis of a system scales well with the size of the
system and its complexity. Indeed, engineers design systems
hierarchically with modules comprising other modules. If
molecular biology is similarly modular, which structures are the
‘‘atomic’’ modules from which larger modules are constructed? In
signalling networks, we may plausibly ascribe this role to protein
subunits and domains [8,9]. Their function as elementary modules
often depends on allosteric transitions: an interaction at one site
alters the structure at a distant site via a conformational change.
Indeed, allostery increases the information-processing ability of a
network because it transforms proteins from passive substrates to
dynamic computational elements [10]. A modular approach to the
analysis and design of biochemical networks should therefore
explicitly describe the computations performed by individual
allosteric proteins.
Efforts to tackle complexity in biochemical networks should also
exploit the modularity of protein structure. Protein structure is
hierarchical, and a given protein often has domains also present in
other proteins or repeated subunits. For example, many signalling
proteins contain SH2 or PDZ domains, and many receptors, ion
channels and enzymes are multimers. In genetic networks,
transcription factors are also often multimers or have a common
DNA-binding domain, such as a zinc finger or homeobox. The re-
use of protein domains is both a simplifying and confounding
feature: once a domain has been characterized, that characteriza-
tion can be used again, but it is also necessary to model molecular
cross-talk between signalling pathways that contain proteins with
similar structures.
In vivo, protein interactions can generate both combinatorial and
regulatory complexity. Combinatorial complexity is an ‘‘explo-
sion’’ in the number of possible species in a system as the number of
proteins and interactions in the system increases. It arises because
the number of states of a module dramatically increases as its
proteins bind ligands as well as each other and as different residues
are covalently modified [11,12]. For example, p53, the so-called
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cellular ‘‘gatekeeper’’, has 37 known modification sites and so
potentially 237 states [13]. Thus, a complete description of the
system potentially requires a combinatorially large number of
chemically distinct species and reactions. In contrast, ‘‘regulatory
complexity’’ is a combinatorial increase in the number of parameters
required to describe the regulatory interactions within a system as
the number of interactions increase. This complexity arises
because the strength of protein interactions depends on the state
of a module, and each state of the module potentially requires a
unique set of parameters to characterize interactions within the
module, with other modules in the network, and with molecules
external to the network. Measuring this number of parameters in
vivo is challenging.
Rule-based modelling addresses combinatorial complexity and
allows biologists to specify the regulatory logic of a system [14].
Examples include BioNetGen [15], Kappa [16], Moleculizer [17]
and StochSim [18]. Rather than explicitly enumerating each
species and reaction in the network, a rule-based model describes a
system as a collection of biomolecules interacting according to a
set of rules. Each rule is a template for a reaction that specifies the
reactants, products and all relevant biochemical parameters. Thus,
combinatorially complex systems are compactly described because
a large number of distinct reactions are subsumed in the template
encoded by a single rule. An algorithm may automatically infer a
complete reaction network prior to simulation or, if the
combinatorial complexity is too great, use alternative techniques
to simulate the system [19,20]. Importantly, some rules also specify
contextual conditions that constrain when an interaction can occur
and hence encode the regulatory logic of the network. For
example, a rule may allow only a doubly phosphorylated MAP
kinase to phosphorylate its substrate.
Rule-based formalisms can describe complex biochemical
systems, but inherently offer little guidance on avoiding a number
of methodological problems. First, using rules to specify the
regulatory logic of a system does not address the system’s
regulatory complexity. Consider G protein-coupled receptors
(GPCRs), which allosterically couple an extracellular ligand-
binding site to an intracellular G protein-binding site [21].
GPCRs can be promiscuous, binding multiple intracellular targets
[22,23]. Supposing a given GPCR can bind one of L different
drugs or endogenous ligands and one of G different G proteins,
then in principle we require LG pair-wise cooperativity parameters
to describe how each ligand regulates the GPCR’s affinity for each
G protein. Thus, the number of regulatory parameters scales with
LG, and the number of rules also scales with LG because each
parameter is part of a rule with distinct contextual constraints.
Promiscuous allosteric proteins can therefore require a large
number of rules and parameters to characterize their interactions.
Second, a module should have a well-described function and be
easily re-used and ‘‘portable’’ between systems, but most rule-
based formalisms are not inherently modular. Modellers typically
treat proteins as ‘‘black boxes’’ and define interactions using
biochemical equations. In such ‘‘interaction-centric’’ approaches,
the regulation of proteins is encoded by rules with ad hoc (system-
specific) conditions that no longer apply when the proteins interact
with different partners. These ad hoc rules obfuscate the
mechanism underlying allosteric regulation because they do not
show explicitly how the intrinsic structural and thermodynamic
properties of allosteric proteins generate their functional proper-
ties. In contrast, a ‘‘biomolecule-centric’’ approach would encode
regulatory logic in the proteins themselves. Fewer changes to rules
would then be required to define how a new set of interaction
partners regulates the protein’s activity. If a model includes protein
domains and subunits, re-use of these components would also be
simplified.
Finally, models generated by rule-based methods should be
thermodynamically correct. In biochemical networks, there are
often sets of reversible reactions that connect into a closed loop,
forming a thermodynamic cycle. In many of these cycles no free
energy is consumed: for example, when proteins bind multiple
ligands, when ligands bind several conformations of a protein, or
when ion channels bind multiple agonists and have closed, open,
and desensitized states. Thermodynamics imposes a mathematical
relationship between the equilibrium constants for all the reactions
involved in such cycles: their product must be unity. Equilibrium
constants cannot therefore be assigned independently. A thermo-
dynamically correct methodology should ensure that a model
satisfies this constraint, ideally by construction.
Here, we present a modular and scalable modelling method-
ology that alleviates the regulatory as well as the combinatorial
complexity of biochemical networks. We first describe our
modelling framework, which uses a thermodynamically grounded
treatment of allostery in which ligands distinguish only the
conformational state of allosteric proteins. We also introduce a
rule-based modelling tool that implements our methodology: the
Allosteric Network Compiler (ANC). We use ANC to examine
how allostery can make macromolecular assembly more effica-
cious. We then show how our modelling framework describes
common mechanisms of allostery by mapping the regulatory
properties of a protein onto conformational changes in the protein
itself and demonstrate how we can ease the analysis of multiple
ligands interacting through an allosteric protein. Next, we discuss
how our approach reduces regulatory complexity and thereby
increases a model’s modularity. Finally, we use our framework to
develop a model of G protein-coupled receptors whose regulatory
complexity scales with (L+G) instead of LG and consequently has
greater predictive power. While our major goal is to introduce a
new modular modelling methodology rather than its implemen-
Author Summary
The complexity of biochemical networks challenges our
ability to create quantitative and predictive models of
cellular responses to extracellular changes. In these
networks, the regulation of allosteric receptors and
proteins by multiple drugs or endogenous ligands
introduces ‘‘regulatory complexity’’ because a large
number of parameters is required to describe such
interactions. Protein interactions also give rise to ‘‘combi-
natorial complexity’’ by generating large numbers of
protein complexes and covalent modification states. To
address these twin problems, we propose a modelling
framework that combines a modular description of protein
structure and function with a rule-based description of
protein interactions. We define the input-output function
of an allosteric protein through its thermodynamic
properties and structural components. We show that our
‘‘biomolecule-centric’’ methodology, in contrast to ad hoc
approaches that emphasize the regulatory logic of
interactions, can reduce the number of parameters
required to model experimental observations. We also
demonstrate how the application of our framework gives
insights into the assembly of macromolecular complexes
and increases the predictive power of a standard model of
G protein-coupled receptors. These benefits are possible in
many systems, given the ubiquity of allostery in biochem-
ical networks. Our research delineates a fundamental
relationship between allostery, modularity, and complexity
in biochemical networks.
Rule-Based Modelling of Allosteric Networks
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tation, we have made ANC and the models we discuss available at:
http://swainlab.bio.ed.ac.uk/anc.
Results
A structurally and thermodynamically grounded rule-
based methodology for modeling allosteric proteins and
biochemical networks is implemented in ANC
Our method is based on the Monod-Wyman-Changeux (MWC)
paradigm of allostery [24]. We assume that allosteric proteins are
dynamic and have one or more structural components, such as
domains or subunits, with distinct conformations. These confor-
mational states have different biological activity – for example, a
basal state with poor affinity to downstream proteins and an active
state that can bind these proteins. Thermal fluctuations cause
these allosteric components to transition between their two
conformations in either a concerted or sequential fashion [25].
Ligands and other molecules interact non-cooperatively with each
conformation of the protein, distinguishing only its conformational
state, and so contribute independently to the equilibrium of the
allosteric transition. Each such contribution is parameterized by a
‘‘regulatory factor’’ C, which gives the fold-change of the
equilibrium constant generated by interactions with the ligand.
We make a similar independence assumption with respect to the
transition state of the allosteric transition such that ligands also
contribute independently to the transition’s kinetic rate-constants.
These contributions to the kinetics are parameterized in terms of
one or more ‘‘W-values’’, which give the effect of modifiers on the
forward and reverse rates of the allosteric transition (see Methods).
Thus, an allosteric protein can be seen as a modular and dynamic
computational device, and we can define the input and output of
each allosteric component. The input is a ‘‘modifier’’, a molecule
that binds to and locally perturbs the structure of the component;
the output is the fraction of time the component spends in each
conformation when the allosteric transition is at equilibrium (see
Methods). Activation corresponds to biasing the equilibrium in favour
of the biologically active state; inhibition corresponds to biasing
towards the inactive state. Depending on the system, modifiers may
be ligands [24], covalent modifications [26,27], the conformational
state of another component [25,28,29], or mutations [30,31].
An ANC model consists of a set of modular structures and
interaction rules. Using our rule-based approach (Tables 1–5 of
Text S1, Figures 1–9 of Text S1) and building on the
thermodynamic framework described in Methods, each molecule
in a system is described using an ANC construct called a structure,
which captures the true structure of a protein in terms of its
components (Figure 1A). ANC-structures contain two types of
components: hierarchical components and interaction sites.
Hierarchical components have two roles. The first is that of
containment and composition: a hierarchical component typically
contains interaction sites but can also contain other hierarchical
components. Hierarchical components may represent a unit of
tertiary structure, such as a protein domain, or of quaternary
structure, for example, a protein with multiple subunits. Their
second role is to undergo conformational transitions if designated
as allosteric, following the two-state model described in Methods.
Interaction sites are of three types: catalytic sites (such as a kinase
or phosphatase), sites that can be covalently modified, and ligand-
binding sites. Next, rules specify the interactions between sites and
how the strength of these interactions depends on the conforma-
tional state or the covalent modifications of a protein (Figure 1B).
If the interaction is a binding reaction, the rule gives the
association and dissociation rates. If the interaction is enzymatic
– such as a phosphorylation or dephosphorylation – then we
assume a Michaelis-Menten mechanism, and the rules give the
rate of formation of the product and the association and
dissociation rates between the sites, which must be a catalytic site
and a covalent modification site.
The overall modelling process for a divalent adaptor protein
and two ligands is illustrated in Figure 1C. Structures and rules are
entered as text and saved to a file (section 12.7 of Text S1). ANC
reads the file, creates an initial set of seed structures, and launches
an iterative compilation algorithm. At each iteration, the
algorithm determines all inter- and intramolecular reactions, the
products created, and their biochemical rates. In a subsequent
iteration, the newly created products may in turn react to produce
yet more species. Once a final biochemical reaction network has
been obtained, it is simulated using deterministic or stochastic
methods (see Methods). The deterministic simulation in Figure 1C
shows how upon binding X, which could represent an activated
receptor, the adaptor A recruits increasing amounts of Y, which
could represent a downstream signalling protein.
Analysis of the cooperativity of ligand binding to a
generic divalent allosteric protein
The generic model of a divalent allosteric protein shown in
Figure 1C (full details in Figure 7 of Text S1) can be used to model
proteins that play other roles than adaptors. For example, A could
be a membrane-bound receptor, X an extra-cellular agonist, and
Y an intracellular signalling protein which binds preferentially to
the active conformation of the receptor. The usefulness and
simplicity of this model motivates us to analyze it mathematically.
In the model, the binding of X and Y to A is cooperative
because binding of X to A changes the affinity of A for Y by a
factor h and likewise the binding of Y to A changes the affinity of A
for X also by a factor h. By coarse-graining over the conformations
of A (Figure 2A, inset), we can express the cooperativity parameter
h as (section 12.1 of Text S1):
h~
(1zKRT )(1zCXCYKRT )
(1zCXKRT )(1zCYKRT )
ð1Þ
where KRT is the allosteric equilibrium constant and CX (or CY) is
the differential affinity of the X (or Y) to each conformation of A.
The cooperativity increases as the degree of bias (CX and CY) that
X and Y exert on the conformational transitions of A increase. We
can also define the apparent affinity of X and Y to this coarse-
grained A:
KX~KRX
(1zCXKRT )
(1zKRT )
,KY~KRY
(1zCYKRT )
(1zKRT )
ð2Þ
These equations relate the underlying parameters of the model to
experimental observables: both the affinity KX of X to A and the
affinity hKX of X to A when A is bound by Y are measurable.
Allostery can make macromolecular assembly robust
even when linker proteins are over-abundant
Counter-intuitively, an excess of some components of a
macromolecular complex can inhibit formation of the complex
[32], [33]. This phenomenon, called the prozone effect, is
strongest for a protein that links two or more separable parts of
a complex. It occurs because the linker protein competes with itself
for the binding of the other components of the complex, and so if it
is present in excessively high amounts, few of the linker proteins
will succeed in simultaneously binding all the other components,
resulting in partially formed complexes.
Rule-Based Modelling of Allosteric Networks
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Here, we show that allostery can mitigate the prozone effect, at
least for a divalent allosteric protein. We consider the divalent
structure A to represent a linking protein with X and Y being the
remaining parts of a complex. In Figure 2A, we demonstrate how
increasing the cooperativity increases the range of concentrations of
A for which assembly of the complex XAY is efficacious (i.e. where
the equilibrium amount of complex exceeds 50% of the maximum
amount). This range increases from 1.3 decades when h=1 to 4.0
decades when h=104, and the maximal amount of complex formed
increases by a factor of 5.7 (Figure 11 of Text S1). Thus, an allosteric
linker protein has a dual benefit in macromolecular assembly: it
both increases the amount of complex when the components are
present in their stochiometric amounts and makes complex
formation more robust to the over-expression of the linker protein.
Allosteric linker proteins could explain the low correlation observed
between over-expression of a linker protein and lethality of that
over-expression in budding yeast [34].
That the efficacy of macromolecular assembly depends strongly
on the value of the cooperativity parameter h suggests that
assembly could be modulated by changing h. Figure 2B shows the
dependence of h on the allosteric equilibrium constant and the
differential affinity of the ligands X and Y. Cooperativity has a
maximum at KRT= (CXCY)
21/2 and thus assembly of the XAY
trimer could in principle be controlled through the binding of a
cofactor or a covalent modification that changes the allosteric
equilibrium constant of A from a value far from its optimum to a
value near the optimum (or vice versa).
A compact, structural and modular representation of
allosteric proteins
There are two well-known mechanisms for generating cooper-
ative behaviour in proteins: concerted and sequential allostery. In
their seminal paper, Monod, Wyman and Changeux introduced a
two-state model to explain cooperative interactions in oligomeric
Figure 1. The Allosteric Network Compiler – modelling elements and methodological flowchart. (A) Example structures. Each structure
has a name (underlined) and comprises a set of named components. Hierarchical components (triangles) represent part or all of a biomolecule and
contain, as denoted by arrows, one or more interaction sites (circles). Left: The structure X represents a simple ligand with a single binding site (circle
with horizontal bar). Centre-left: The structure A represents a generic, divalent allosteric adaptor protein. The adaptor’s hierarchical component is
allosteric (indicated by a tilde) and transitions between low (R) and high-affinity (T) conformational states. The dashed lines indicate that each binding
site acts as a modifier for the allosteric transition, with each interaction parameterized by the indicated W-value, and that ligands can distinguish each
conformation. Centre-right: The structure R is a simplified model of the nicotinic aceltylcholine receptor (nAChR), following Edelstein et al. [67] but
without desensitized states. The allosteric component transitions between closed (C) and open (O) states. Right: The structure K is a model of a
mitogen activated protein kinase (MAPK) with two activating phosphorylation sites (circles with vertical bar and a grey dot as a placeholder for the
state) and a catalytic site (circle with cross). The allosteric component transitions between inactive (I) and active (A) states. Both the phosphorylation
sites and the catalytic site are modifiers of the allosteric transition: each successive phosphorylation biases the equilibrium of the enzyme towards the
active state by a regulatory factor CY1 or CY2. Each of these interactions is also parameterized by a distinct W-value. (B) Example rules. A pair of
binding rules for the adaptor A and the ligand X specify the association and dissociation rates of AX with X when AX is in the R and T states, a similar
pair (not shown) specifies the rates for AY and Y, and we define the affinities KRX and KTX implied by the rates (in gray, e.g. KRX = kfRX/kbRX). A covalent
modification rule for the kinase K acting on an unphosphorylated (open dot) downstream target Y follows the Michaelis-Menten mechanism for
enzyme-substrate interactions and yields a phosphorylated substrate (filled dot). (C) Methodological flowchart. In a model of the adaptor protein A
and its ligands X and Y (Figure 7 of Text S1), the rules state that both ligands bind with higher affinity to the T state of the adaptor. This model is
compiled by ANC to generate a reaction network where horizontal transitions correspond to conformational changes, vertical transitions correspond
to binding the ligand X, and transitions into the page represent binding the ligand Y. KRT is the allosteric equilibrium constant, while the regulatory
factors CX and CY are the differential affinity of the ligands to each conformation of A and are calculated by ANC using the rate constants given in the
rules (e.g. CX = KTX/KRX). The reaction network is converted into ordinary differential equations by Facile and these are simulated in Matlab to compute
the output response of the system (bound AY vs. X, with ATOT = 1, YTOT = 1, KRT = 10
23 KRX = 0.1, KTX = 10, KRY = 0.01, KTY = 100, arbitrary units).
doi:10.1371/journal.pcbi.1000975.g001
Rule-Based Modelling of Allosteric Networks
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enzymes and proteins [24]. They proposed that all subunits of
such proteins undergo a concerted, reversible, and quaternary-level
transition between two conformational states. Ligand-binding to
each conformation is non-cooperative, but each conformation
differs in its affinity for ligands and this difference gives rise to
cooperative effects. Subsequently, Koshland, Nemethy and Filmer
lifted the assumption of concerted transitions with their sequential
model, in which each subunit transitions individually between two
conformational states [25]. This model can explain negative
cooperativity in oligomeric proteins. It assumes, however, that
ligands cause an instantaneous conformational change, or an
induced fit, in the structure of the subunit. Both the concerted and
induced fit assumptions can be relaxed and are special cases of the
general allosteric model of Herzfeld and Stanley [28].
ANC-structures can be used to implement these models of
allosteric regulation. A concerted model of a generic, homote-
trameric protein is shown in Figure 3A. The transition between the
two conformations, labelled R and T, is concerted because a single
allosteric component contains all subunits. Cooperativity will arise
if a ligand has a higher affinity for one state, say the R state, and if
the unligated protein is mostly in the alternate state T. Then, once
bound by ligand, the protein spends more time in the R state and
so favours the binding of additional ligands. In contrast, a
sequential model has an ANC-structure with four allosteric
components, each with r and t states. Figures 3B and 3C show
how we implement the tetrahedral and square geometries
described by Koshland et al. [25] through different configurations
of the allosteric coupling between subunits. Two components are
allosterically coupled if the conformation of one component biases
the conformational equilibrium of the other component, and vice
versa. For example, in Figures 3B and 3C, ligand binding favours
the r state of an individual subunit, and this subunit when in its r
state favours the r state in those subunits to which it is allosterically
coupled and so generates a cooperative response. Finally, we
illustrate the general approach with the tertiary two-state model
shown in Figure 3D, which allows both quaternary, R«T and
tertiary, r«t, allosteric transitions [29]. Here, ligand binding
favours r at the bound subunit because of the ligand’s higher
affinity for r. Cooperativity arises because the R state of the
quaternary structure reciprocally favours the r state of the tertiary
subunits. Thus, a subunit in the r state favours R at the quaternary
level and so favours subunits not yet bound by ligand to also be in
the r state, promoting binding of additional ligands. Our ANC
implementation of the tertiary two-state model correctly repro-
duced the Henry et al. model, which has 252 molecular species
[29].
An advantage of ANC is its ability to easily formulate and
simulate mathematically complex models. For example, we will
show that the cooperativity of an allosteric protein binding a
ligand, such as a transcription factor binding an inducer, can be
substantially changed through adding a competing ligand.
Although a mathematical analysis of various allosteric models
with two competing ligands exists [35], little is known about
multiple ligands and the analysis is cumbersome for the sequential
model despite simplifying assumptions. Using ANC, we charac-
terized the binding cooperativity of a ligand L0 to a tetrameric
allosteric protein in the presence of one of three different
competing ligands for both the concerted and sequential models
(Figure 4). In the absence of competitors, the Hill coefficients for
binding L0 in the concerted and sequential models were ,2.8 and
,2.2 respectively. By increasing the concentration of the
competitor ligand L1, which binds preferentially to the same
conformation as L0, the Hill coefficient decreased progressively to
1 (i.e. no cooperativity). With ligand L3, which binds preferentially
to the low affinity state for L0, the Hill coefficients increased to
,3.6 and ,3.4. With ligand L2, which binds with equal affinity to
all conformations, the Hill coefficient did not change. With
competitors L2 and L3, the EC50 of L0 binding increased but at
low concentrations of L1, the EC50 of L0 was slightly lower
(Figure 12 of Text S1).
Figure 2. Allostery makes macromolecular assembly robust and controllable. (A) Effect of allostery on macromolecular assembly when a
linker component is over-expressed. Each curve shows the equilibrium concentration of the XAY trimer against the total amount of A. The total
amount of X and Y was unity, while KRT and the affinities of X and Y to each conformation of A (KRX, KRY, KTX, KTY) were chosen to yield a desired value
of h and with KX = KY = 1. Inset: A coarse-grained version of the divalent protein model of Figure 1C sums over the two possible conformations of A
and shows that with KX, KY and the concentrations of X and Y held constant, the efficacy of assembly depends only on the cooperativity parameter h.
(B) Regulation of cooperativity and assembly. The value of h depends on the other parameters of the model through Equation 1, which is plotted
against KRT on one axis and CX and CY (assumed equal) on the other. Increasing CX and CY always increases cooperativity, however h has a maximum
value as KRT is changed.
doi:10.1371/journal.pcbi.1000975.g002
Rule-Based Modelling of Allosteric Networks
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In addition to ligand binding, our methodology also describes
other mechanisms for allosteric regulation that are ubiquitous in
cellular signalling. Phosphorylation or other post-translational
modifications, dimerization, receptor clustering and point muta-
tions can also regulate or change protein function. Our
thermodynamic framework (see Methods) unifies the treatment of
such heterogeneous modifiers of protein activity. In section 12.4 of
Text S1, we discuss how dimerization and ligand binding jointly
regulate the activity of the epidermal growth factor receptor, and
how ligand binding combines with methylation to regulate a
chemotaxis receptor (Figure 13 of Text S1).
Encoding regulatory logic through intensive rather than
extensive parameters reduces regulatory complexity and
increases modularity
We can distinguish two types of parameters that affect
modularity in different ways: intensive parameters and extensive
parameters. Intensive parameters describe the conformational
transitions and intramolecular interactions of a protein and, as
such, are modular because they are inherent to the protein and
independent of the protein’s interaction partners. Therefore, we
associate intensive parameters with a protein’s ANC-structure. In
contrast, extensive parameters describe the interactions of a
protein with other biomolecules and increase in number as the
number of these interactions increase. Extensive parameters,
contained in rules for interaction, are the ‘‘wiring’’ between
modules and are non-modular because they depend on the system
in which the protein functions. Regulatory complexity occurs
when the number of extensive parameters describing a system
scales combinatorially with the number of interactions in the
system.
Figure 3. Classic and general models of allostery and protein
structure are described by our modelling framework. (A) A
concerted model of a tetrameric allosteric protein has one allosteric
component and 4 identical interaction sites to represent each subunit.
The dashed lines indicate that each ligand-binding site is a modifier for
the R«T allosteric transition and all 4 interactions are identically
parameterized by WLB. (B) In a sequential model of the protein, a top-
level hierarchical component comprises 4 identical allosteric compo-
nents that individually change conformation and bind ligand. These
components are allosterically coupled (dashed lines) such that each
subunit is equivalent and a modifier for all neighbouring subunits – the
‘‘tetrahedral’’ model. The strength of the coupling is given by the
regulatory factor CS and the effect of each modifier on the kinetics of
coupled components is parametrized by WLB and WS. (C) Altered lateral
interactions between subunits gives the ‘‘square’’ model. (D) A tertiary
two-state model has one allosteric hierarchical component containing 4
identical allosteric components, each with a ligand-binding site. The
upper quaternary component is allosterically coupled to each tertiary
component with strength C and the tertiary components are coupled
to their binding site. The effect of the quaternary conformation on the
kinetics of the tertiary transition is given by WQ, and the reciprocal
interaction is parameterized by WT. (E) The ligand for all four models.
(F) Rules for the concerted model in panel A. (G) Rules for the models in
panels B, C and D.
doi:10.1371/journal.pcbi.1000975.g003
Figure 4. Cooperative binding of competitive ligands to the
concerted and sequential models. The allosteric equilibrium of an
unligated protein favours a state T (or t). Ligand L0 binds preferentially
to state R (or r) and so binds cooperatively to the protein. The Hill
coefficient of the dose-response function for L0 (the number of L0
bound to the protein versus the concentration of L0) was measured in
the presence of increasing concentrations of three competing ligands:
L1 favours the R state; L2 is neutral; L3 favours the T state.
Concentrations of competing ligands are normalized to the EC50 of
their own occupancy function. For the concerted model KRT = 10
3; for
the sequential (tetrahedral) model Krt = 0.1 and CS = 10. Ligand affinities
were set to KRLi = KrLi = (Ci)
21/2 and KTLi = KtLi = (Ci)
1/2 with C0 =C1 = 0.01
(prefers R or r), C2 = 1 and C3 = 100 (prefers T or t).
doi:10.1371/journal.pcbi.1000975.g004
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Our biomolecule-centric methodology minimizes regulatory
complexity. For example, we analyzed a generic model of an N-
valent, two-state protein where each of the N binding sites is
unique and binds exactly L ligands (section 12.5 and Table 6 of
Text S1). In an ‘‘interaction-centric’’ modelling approach, there
are no intensive parameters and the number of extensive
parameters scales as LN. In the ‘‘biomolecule-centric’’ methodol-
ogy of ANC, there are 2 intensive parameters and the number of
extensive parameters scales linearly with the number of interac-
tions NL. Using our methodology can therefore yield large savings;
for instance if N= 6 and L= 5, we have 91 independent rate
constants rather than over 233,000 (Table 7 of Text S1). Thus, by
encoding the regulatory logic of proteins with intensive rather than
extensive parameters, we reduce regulatory complexity. We
therefore improve the model’s modularity because only extensive
parameters change when a model is updated.
Refactoring yields a scalable and modular GPCR model
that can explain functional selectivity
Using our biomolecule-centric modelling framework, we can
convert a non-modular model into a modular one. Such
refactoring is also useful when a protein has more than two
conformational states, unlike the core allosteric components in
ANC-structures. To illustrate, we introduce a new model for the
activation of G protein-coupled receptors (GPCRs). GPCRs are a
common target for pharmaceutical drugs [36]. Such drugs include
agonists that promote activation of the receptor, inverse agonists
that promote deactivation of the receptor, and antagonists that by
binding to the receptor block the action of agonists.
Although several allosteric models have been proposed [37,38],
we will consider the cubic ternary complex model [39] because
this model describes the constitutive activity of a GPCR, the action
of inverse agonists and antagonists, and how some inverse agonists
can cause a GPCR to recruit G proteins but remain inactive [40].
The model also explains the functional selectivity of receptors (also
called agonist trafficking, ligand-biased agonism, or protean
agonism) [41] through the notion of active states of the receptor
that are specific to a ligand or a G protein [38,42]. However, the
model does not include receptor homo- or hetero-oligomerization
[43–48], or the possibility that GPCRs form stable, pre-assembled
complexes with downstream proteins [49,50].
A naive implementation of the cubic ternary complex model in
our framework uses a divalent ANC-structure with a single
allosteric component (Figure 5A, C). This implementation
captures Weiss et al.’s assumption that the receptor has only two
conformational states. However, it does not capture the cooper-
ative binding of a ligand to either the inactive or active states of the
receptor because such binding is incompatible with the paradigm
that each modifier contributes independently to the equilibrium
constant of the allosteric transition [24]. This cooperative effect is
described in Weiss et al.’s model through the cooperativity
parameters c and d. However, these parameters are extensive
and specific to each combination of ligand and G protein. They
therefore introduce regulatory complexity.
To resolve this difficulty, we propose a sequential allosteric
model of the GPCR with two coupled allosteric components: an
extracellular allosteric component, which binds a ligand, and an
intracellular allosteric component, which binds a G protein
(Figure 5B, D). The ligand and the G protein interact
simultaneously with both allosteric components. They therefore
‘‘see’’ four possible conformations of the receptor instead of two.
These conformations are implied in the cubic ternary complex
model because each ligand has four distinct affinities to the
receptor. However, none of the extensive parameters in our model
are cooperativity parameters specific to a ligand-G protein pair,
thus eliminating regulatory complexity.
Our quartic ternary complex model can be projected onto the
cubic model by defining coarse-grained variables that sum over
the conformations of the extracellular allosteric component
(Figure 5 and section 12.6 of Text S1). The ‘‘inactive’’ and
‘‘active’’ states in the cubic model therefore correspond to a
mixture of conformational states, providing a mechanism for how
different ligands induce an apparently unique conformation of the
activated GPCR with a distinct affinity for the G protein [51]. In
our model, each ligand uniquely affects the allosteric equilibrium
of the extracellular domain and therefore the fraction of time that
the receptor is in the s and t states, which in turn uniquely
modulates the affinity of the active GPCR for the G protein.
Our quartic model for the GPCR is more modular and
parsimonious than the cubic model because it includes a
structurally and biophysically plausible mechanism for how ligands
and G proteins interact cooperatively with the GPCR. We encode
the logic of these regulatory interactions in the protein’s ANC-
structure using intensive parameters, rather than in ad hoc rules
with extensive parameters. Our ‘‘refactored’’ model has 11
parameters (3 of which are intensive) compared to the 7
parameters of the cubic model (1 of which is intensive) and
double the number of states. This initial cost for increased
modularity and ‘‘portability’’ becomes a benefit as the number of
types of ligands and G proteins increases. The number of extensive
parameters in our model scales linearly with the number of
interactions; in the cubic model, the number of extensive
parameters scales combinatorially. For example, suppose we wish
to model 4 different ligands that activate the thyroid-stimulating
hormone receptor. In human thyroid membranes, this GPCR can
activate at least 10 different G proteins [22]. With 4 ligands and
10 G proteins, our quartic model is almost twice as parsimonious
as the cubic model, requiring 59 rather than 109 parameters.
The quartic model also has more predictive power than the
cubic model and therefore can be more rigorously tested. For each
pair of ligands and G proteins, the cubic model requires the
specification of two cooperativity parameters, d and c, specific to
that pair. It is therefore limited in the predictions it can make. For
example, for each new G protein added to the system, new
cooperativity parameters are needed for all previously character-
ized ligands to be able to predict the new G protein’s GPCR-
mediated response to these ligands. In contrast, the quartic model
is completely characterized for the new target pathway by
measuring four extensive parameters – one for each conformation
of the GPCR – and we can then predict the GPCR-mediated
response to all ligands. In particular, we can predict the rank order
of potency of the ligands to activate the new pathway, a standard
means to compare agonists in pharmacology, and detect functional
selectivity [51].
Like the cubic model, the quartic ternary complex model also
explains functional selectivity, though this is not obvious
considering that these models cannot be related through a simple
projection when multiple ligands and G proteins interact with a
single receptor. Indeed, in the quartic model d and c are not free
parameters but are correlated because of their dependence on
underlying rates. We therefore simulated the GPCR-mediated
response to several ligands that cause (in)activation of two different
G proteins (Figure 6A and 6B). Ligand L1 has the greatest ability
to activate G protein G1 as measured by its potency (2log(EC50)
of the response) and efficacy (maximal activation). For G1, ligand
L2 has intermediate potency and efficacy and L3 has the lowest
potency and efficacy. Also, L1 is better able to activate G1 than
G2. If the receptor had only a single active state, we would
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therefore infer that this state must have a poorer ability to bind
and activate G2 and would expect that L2 should also have a
decreased ability to activate G2. The potency and efficacy of L2 on
G2 is, however, greater than that of L1 indicating a reversal in the
rank order of the potency and efficacy of L1 and L2. Also, ligand
L3 is an agonist for G1 but an inverse agonist for G2. These
observations of agonists selectively (in)activating distinct target
pathways cannot be reconciled with a model comprising a single
active state of the receptor. Functional selectivity can also be
observed for the repression of activity by inverse agonists because
there are also two inactive states of the receptor (Figure 6B).
The quartic model is modular and therefore is easily extended
to include additional signalling interactions such as the regulation
of the receptor by allosteric ligands [52], [38]. Also, by adding
dimerization sites, we could incorporate existing models of
dimerization of GPCRs [47]. Some GPCRs may also oligomerize
in vivo, for instance by forming tetramers [53]. We could model
oligomerization by concatenating multiple receptor models within
a larger ANC-structure through modular composition. A starting
point could be one of the models of Figure 3, but substituting for
each subunit the ANC-structure for a GPCR and, as appropriate,
adding allosteric couplings to model inter-receptor interactions.
Discussion
Biochemical networks are complex yet modular: networks
exhibit both combinatorial and regulatory complexity, but
individual proteins have intrinsic functional properties that
determine how they detect and process information. Complexity
is also reduced because similar proteins or similar protein domains
appear in many signalling pathways and often interact with similar
protein partners. We propose a modelling methodology, embodied
by ANC, that exploits the modularity of proteins to reduce the
complexity of modelling biochemical networks. Given modular
ANC-structures, which encode a protein’s regulatory properties,
adding new interactions to an ANC model usually requires
substantially fewer parameters than with other rule-based models,
particularly as the promiscuity of binding of proteins, and hence
the complexity of the network, increases. ANC-structures are also
portable because different signalling pathways are modeled by
Figure 5. Cubic and quartic ternary complex models of a GPCR in our modelling framework. The mapping between the cubic (A) and
quartic (B) models shows how the two models are related. (A) A naive implementation of the cubic ternary complex model. The ANC-structure R has
one allosteric component which transitions between a low-affinity, inactive (i) state and a high-affinity, active (a) state with the indicated equilibrium
constant (in gray). LB and GB are binding sites for an extracellular ligand L (not shown) and an intracellular target G protein (not shown). In the
corresponding cubic, 8-state transition diagram Kact is the unligated allosteric equilibrium constant, Ka and Kg are ligand affinities to the reference
(inactive) state, and a and b are ratios of affinities. We parenthesize the cooperativity parameters d and c to indicate that these parameters of the
cubic ternary complex model have to be added as ad hoc rules to the naı¨ve implementation. (B) In our quartic ternary complex model, an ANC-
structure R comprises two allosteric components: the extracellular domain ED transitions between low and high-affinity states (s and t); the
intracellular domain ID transitions between inactive and active states (i and a). These transitions are reciprocally linked (dashed line) so each domain
acts a modifier of the other with the interaction parameterized by C and W. The binding sites are allosterically coupled to both allosteric components,
therefore each ligand ‘‘sees’’ 4 possible conformations of the receptor. In the quartic state-transition diagram KactG and KactL are the unligated
allosteric equilibrium constants, G is the regulatory factor linking the s«t and i«a transitions, Ka9 and Kg9 are ligand affinities to the reference state si,
and a and b are ratios of ligand affinities of the subscripted state relative to the reference state. For clarity, we show only the unligated s«t transition.
(C) Rules for the cubic ternary complex model showing the rate and equilibrium constants for ligand and G protein binding. (D) A subset of the rules
for the quartic ternary complex model shows the rate and equilibrium constants for ligand binding. A similar set of rules specifies rate and
equilibrium constants for binding G protein (Figure 9 of Text S1).
doi:10.1371/journal.pcbi.1000975.g005
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simply ‘‘re-wiring’’ proteins rather than through writing new ad hoc
rules encoding the regulatory logic specific to each pathway.
In our methodology, models are structured to minimize
regulatory complexity both to avoid over-fitting data and because
large numbers of biochemical parameters are difficult to measure in
vivo. Indeed, our modelling framework reflects a natural division
between two classes of parameters: ‘‘intensive’’ parameters describe
the allosteric transitions and intramolecular interactions of a
particular protein and are attributes of ANC-structures; ‘‘extensive’’
parameters describe the interactions of the protein with other
biomolecules and are associated with rules. In different biochemical
networks, only the extensive parameters of a protein change.
Through its assumption that a ligand or substrate distinguishes only
the conformation of a protein or enzyme and not its occupancy or
state of covalent modification at distant sites, our modelling
framework substantially reduces the number of extensive parame-
ters required: their number scales linearly, rather than combinato-
rially, with the number of interactions. This reduction in extensive
parameters allows a model for the interaction of a protein with
individual ligands to also predict the response to mixtures of ligands
with no additional parameters [54]. We have shown that
interference with a competing ligand can either increase or decrease
the cooperativity of the response to the original ligand (Figure 4) – a
potentially useful mechanism of control.
Our methodology reduces the regulatory complexity but
increases the combinatorial complexity of a system because each
conformation of an allosteric protein introduces a new state. Thus,
a reduction in regulatory complexity incurs the computational cost
of modelling additional species. Nevertheless, recent advances in
rule-based modeling have introduced new methods that allow fast
simulation of systems with large numbers of chemical species and
reactions [17,19,20,55–57]. By focusing on avoiding an exponen-
tial increase in extensive parameters in systems with promiscuous
binding, our methodology both complements and potentially
benefits from these innovations.
We also make a first step at integrating free energy-based
constraints into a rule-based modelling framework, adding to
earlier work on imposing detailed balance in models of
biochemical networks [58–61]. By automatically computing all
dependent extensive parameters associated with allosteric transi-
tions – the allosteric equilibrium and rate constants for each
ligated and modified state – from the appropriate independent
parameters, ANC prevents the modeller from incorrectly specify-
ing these parameters. Thus, cycles comprising allosteric transitions
are biophysically correct by construction. For complex models
with a combinatorially large number of occupancy states and
covalent modifications, this automation is essential.
Two other advantages of our modelling framework are
significant. First, ANC-structures enable a coarse-grained hierar-
chical description of physical structure by requiring the specification
of protein domains and if desired tertiary and quaternary structure,
including oligomeric receptor clusters. ANC-structures can also
model the internal geometry of a protein by describing those
domains of the protein that interact allosterically and those that do
not (Figure 3). Second, the thermodynamic framework underpin-
ning our method offers a systematic and unified way to model how
proteins integrate heterogeneous inputs such as ligands, phosphor-
ylations, or even small mutations to compute an output response.
Our modelling framework encourages the modeller to develop a
mechanism to explain the regulatory properties of a protein and
hence to build models that have predictive power and so can be
experimentally tested. For example, an ANC model of the
activation of GPCRs suggests that the well-known cubic ternary
complex model has implicitly coarse-grained some conformations
of the GPCR. By including these conformations in an ANC-
structure, our new quartic model prevents over-fitting and has the
potential to predict the rank order of potency and efficacy of
ligands acting through a GPCR. This model of the GPCR has two
linked allosteric components, each with just two conformational
states that interact independently with other molecules. These
mechanistic assumptions do not, however, apply to the GPCR as a
whole, which has four conformational states. Thus, while the two-
state assumption may not hold for all proteins, other mechanistic
models can be accommodated within our framework.
Figure 6. Functional selectivity of agonists in the quartic ternary complex model. (A, B) We simulated the GPCR-mediated (in)activation
two target G proteins by several ligands. A dose-response for each ligand and G protein pair shows the amount of receptor species capable of
signalling (RsaG+RtaG+LRsaG+LRtaG) as a fraction of the total number of receptors and against the concentration of ligand (arbitrary units). The
concentrations of receptor and G protein are unity. Parameter values: KactL = 1, KactG = 0.05, C= 1, affinities for L1 are given by: (Ka9, at, aa,
aat) = (10,0.1,10,1), for L2: (1,20,20,400), L3: (0.1,10,10,0.01), L4: (100,0.1,0.4,0.01) L5: (20,20,0.05,5), G1: (Kg9, bt, ba, bat) = (10,0.1,10,1) and G2:
(1,10,10,100).
doi:10.1371/journal.pcbi.1000975.g006
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Having allostery at its centre, our framework can suggest simple
mechanisms through which the cell might regulate and increase
the efficacy of cellular processes. For example, the assembly of
macromolecular complexes can be considerably undermined
through the prozone effect when linker proteins are over-expressed
[32]. Consequently we might expect that expression of the
components of macromolecular complexes is tightly regulated.
Such regulation can be complex and expensive. Yet modelling
with our framework suggests that if allosteric proteins are part of
the macromolecular complex and if the linker proteins are
allosteric then the prozone effect can be substantially reduced
and without energy input (Figure 2A).
A challenge in designing synthetic biological systems is to have
predictive modelling tools. Here, ANC has several potential
advantages. First, the modularity of ANC-structures allows models
of synthetic systems to be straightforwardly extended: for example,
as different synthetic subsystems are combined to generate more
complex behaviour [7]. Second, through its rule-based modeling
and the specification of rules of interaction between protein
components rather than between proteins, ANC naturally models
molecular cross-talk between synthetic sub-circuits in a larger
synthetic circuit and between a synthetic circuit and the endogenous
biochemistry (if a rule-based model of endogenous signalling is
available). In both cases, ANC will find and model interactions if
proteins are present that happen to have complementary binding
domains. Such interactions could, for example, affect the formation
of macromolecular signalling complexes (Figure 2) or change the
Hill coefficient of the response of a crucial pathway (Figure 4).
Finally, an ANC model includes background activity in all enzymes
because control of each enzyme is described by an allosteric
transition between inactive and active conformations. This
transition will occur regardless of the presence of input signals to
the system, although the probability of such occurrences can be
small. Like molecular cross-talk, background activity can cause a
synthetic circuit to deviate substantially from its designed behaviour.
Faced with the complexity of cellular signalling and genetic
networks, researchers are developing new computational methods
to quantitatively model and predict cellular behaviour despite that
complexity. In this spirit, we have identified and discussed a
distinct form of complexity – regulatory complexity – which arises
from the allosteric regulation of proteins. Combining and
extending established biophysical principles with more recent
rule-based methods, we propose a modular and scalable
methodology, exemplified by our Allosteric Network Compiler,
to describe the complexity of cellular signalling. By emphasizing
the allosteric control of proteins, we capture the inherent
modularity of protein structure and function exploited by cells
themselves. Our method is a general, principled and simplifying
addition to any modeling framework.
Methods
Thermodynamic framework
To compute how multiple modifiers collectively bias the
conformational equilibrium of an allosteric component, we use
thermodynamics [62].We arbitrarily designate one conformation as
the reference state R and the alternate conformation as T. If we let
DGRT be the difference in free energy between the R and the T
conformations in the absence of any modifiers, then the difference in
free energy in the presence of N modifiers is, quite generally [63],
DG’RT~DGRTz
XN
i~1
DG(i)RTz
XN
i~1
XN
j~iz1
DG(ij)RTz . . . ð3Þ
where we include contributions of free energy to the new allosteric
equilibrium that are determined by each modifier alone, by pair-
wise interactions between modifiers, and by all higher order
interactions.
We assume that all modifiers interact independently (non-
cooperatively) with each conformational state of the protein
component, with the energy of interaction to the R state of the
component given by DG(i)R and to the T state by DG
(i)
T for the
modifier indexed by i. Consequently, the free energy required to
apply a modifier to each conformation does not depend on the
presence or absence of other modifiers – a modifier can only
distinguish the conformational state of the component. Therefore
we need consider just the first order terms of equation (1) and
ignore higher order interactions:
DG’RT~DGRTz
XN
i~1
DG
(i)
RT ð4Þ
For each modifier, a reversible thermodynamic cycle exists around
which the change in free energy must be zero. For example,
equilibria exist between the R and the T states of the component,
between the modifier i being applied to the R state (a free energy
change of DG(i)R ), the modifier being applied to the T state (a free
energy change of DG
(i)
T ), and between the R and the T states of the
modified form of the component. To have no change in free
energy around this cycle implies that DG
(i)
RT~DG
(i)
T{DG
(i)
R .
Hence, we have:
DG’RT~DGRTz
XN
i~1
(DG
(i)
T{DG
(i)
R ) ð5Þ
From statistical mechanics, we know that the equilibrium constant
between any two states of a system, say A and B, is connected to
the difference in their free energy through the expression
KAB~e
{DGAB=kT
Therefore, we may exponentiate equation (3) to find the
corresponding equilibrium constant:
K ’RT~KRT P
N
i~1
Ci, where Ci~e
{(DG
(i)
T
{DG
(i)
R
)=kT ð6Þ
with kT denoting the product of Boltzmann’s constant and
temperature.
Equation (6) describes the input-output function of an allosteric
component, which may embody a domain, a subunit, or an entire
protein. The output K ’RT is the allosteric constant of the
component under the effect of N modifiers. It is obtained by
multiplying a baseline equilibrium constant KRT with each
‘‘regulatory factor’’ Ci, which describes the effect of an input
modifier i on the allosteric equilibrium. If the modifier is a ligand,
then Ci is the ratio of the ligand’s affinity to each conformation. If
the modifier is a covalent modification such as a phosphorylation,
the regulatory factor is an independent parameter related to the
free energies required to phosphorylate each conformation. If the
modifier is another allosteric component to which the component
is allosterically coupled (e.g. Figure 3B–D), then Ci is an
independent parameter related to the free energy of interaction
of the T form of the modifier with each conformation of the
allosteric component, and gives the fold-change in the allosteric
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equilibrium constant induced by the T form of the modifier. When
this modifier is in its reference state, which we label R, the output is
by definition unchanged and the regulatory factor is not applied.
To compute how the kinetics of a component’s allosteric
transition are affected by the presence of modifiers, we first write
the forward and backward rate constants for the unmodified
component in terms of the free energy difference between the
transition state (denoted {) and each conformational state [64]:
kRT~Ce
{DGR{=kT ð7aÞ
kTR~Ce
{DGT{=kT ð7bÞ
To obtain the rate constants for a modified state, the simplest
approach is to assume a constant pre-exponential factor C and that
modifiers contribute independently to a change in the free energy
of the transition state (section 11.2 of Text S1). The assumption of
independence is not arbitrary: at the core of the MWC paradigm
of allostery is the assumption that modifiers contribute indepen-
dently to the free energy of each conformational state. Here we
extend this idea to the transition state of the allosteric transition.
As a result, modifiers independently affect the kinetic rates, just as
they do the equilibrium constant, and we can write:
k’RT~kRT P
N
i~1
(Ci)
Wi ð8aÞ
k’TR~kTR P
N
i~1
(Ci)
Wi{1 ð8bÞ
for parameters Wi.
We choose this parameterization because Wi =Wj implies the
existence of a linear free energy relationship for two modifiers i
and j (section 11.3 of Text S1). A linear free energy relationship
[65] is a common, simplifying assumption in biophysical models:
in a set of related reactions, the logarithm of a transition rate is
assumed to be linearly related to the logarithm of the equilibrium
constant [31,66]. The parameter W denotes the proportionality
constant. Assuming a linear free energy relationship to model
simultaneous modifiers, for example in models of hemoglobin or of
the nicotinic acetylcholine receptor [29,66,67], also implies that
these modifiers independently affect the conformational transition,
with each effect parameterized by the same value of W (section
11.3 of Text S1).
Validation, testing, modelling and simulation
We validated our overall methodological flow (Figure 1C) and
verified the output of ANC by implementing and simulating an
allosteric model [68] of the signalling protein calmodulin (Figure
10A and Figure 10B of Text S1). Binding of calcium to calmodulin
modulates its affinity for downstream effectors. We confirmed that
ANC correctly generates the 352 biochemical equations of the
model of Stefan et al. and that our simulation results were
consistent with theirs, using their experimentally derived param-
eter values (Figure 10C of Text S1).
ANC possesses a number of features which ease modelling and
simulation of biochemical networks. First, ANC allows users to
parameterize a model so that parameter values can be changed
after compilation. Also, ANC supports stimuli, through which the
user can apply input waveforms to specified nodes in the network,
and probes – user-defined collections of molecules – to measure
network output. Finally, ANC allows the creation of ad hoc
regulatory conditions to support interaction-centric approaches.
Such ad hoc conditions, however, reduce the modularity and
scalability of a model and so do not play to the strength of our
methodology.
Using Facile [69], an application distributed with ANC, we can
export an ANC-compiled network to standard tools such as
Matlab, XPP, Maple or Mathematica for deterministic simulation
or analysis, to EasyStoch for stochastic simulation [70], or to
SBML [71].
Limitations of method
The current implementation of ANC has three principle
limitations. 1) The reaction network is enumerated, so ANC’s
performance may degrade significantly if the compiled network is
large. 2) Only rules for binding and Michealis-Menten interactions
can be created. 3) While ANC supports unimolecular association
and dissociation, detailed balance is enforced only for cycles
comprising purely bimolecular associations.
Supporting Information
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